Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Vera Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 84 | +9 |
| Shares | 38.1M | 919.4K | 39.3M | +2.05M (+5.5%) |
| Value | $611.9M | $14.8M | $538.2M | −$59.0M (−9.9%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Vera Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 1,226,147 | $16.8M | 0.02% |
| AXA S.A. | 270,993 | $3.72M | 0.01% |
| D. E. Shaw & Co., Inc. | 158,186 | $2.17M | 0.00% |
| Rafferty Asset Management, LLC | 136,377 | $1.87M | 0.01% |
| Renaissance Technologies LLC | 87,200 | $1.20M | 0.00% |
| Wellington Management Group LLP | 84,506 | $1.16M | 0.00% |
| Voloridge Investment Management, LLC | 69,671 | $955.2K | 0.00% |
| Swiss National Bank | 48,700 | $667.7K | 0.00% |
| Citadel Advisors LLC | 44,294 | $607.3K | 0.00% |
| XTX Topco Ltd | 32,048 | $439.4K | 0.08% |
| HighVista Strategies LLC | 30,902 | $423.7K | 0.20% |
| Gsa Capital Partners LLP | 29,970 | $411.0K | 0.04% |
| Profund Advisors LLC | 23,114 | $316.9K | 0.02% |
| Credit Suisse AG | 15,923 | $218.3K | 0.00% |
| Mariner, LLC | 11,038 | $151.3K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 5,790 | $79.4K | 0.00% |
| Hall Laurie J Trustee | 600 | $8.00K | 0.00% |
Sold out (8)
Institutions that held Vera Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Millennium Management LLC | 333,689 | $5.36M |
| Baker Bros. Advisors LP | 146,464 | $2.35M |
| Simplex Trading, LLC | 70,522 | $1.13M |
| Octagon Capital Advisors LP | 70,000 | $1.12M |
| Trexquant Investment LP | 53,474 | $858.3K |
| Innovis Asset Management LLC | 21,673 | $347.9K |
| PDT Partners, LLC | 18,714 | $300.4K |
| Marshall Wace, LLP | 14,699 | $235.9K |
Not filed for Q3 2023 yet (1)
Institutions that held Vera Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 919,352 | $14.8M |